EGFR and breast carcinoma: The ultrasound (US) photoacoustic dual image-guided PTT in a breast cancer mouse model with the newly synthesized anti-EGFR-MPB nanocomposite (Fig. 1) could be a promising therapeutic approach with enhanced targeted efficiency.